All Stories

  1. Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy

    Article • Vaccines, September 2023, MDPI AG

    Dr. Don J Diamond

  2. Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants

    Article • iScience, August 2022, Elsevier

    Dr. Don J Diamond

  3. Synthetic modified vaccinia Ankara vaccines confer potent monkeypox immunity in non-human primates and healthy adults

    Article • July 2022, Cold Spring Harbor Laboratory Press

    Dr. Don J Diamond

  4. COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants

    Article • iScience, June 2022, Elsevier

    Dr. Don J Diamond

  5. Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity

    Article • Blood Advances, March 2022, American Society of Hematology

    Dr. Don J Diamond

  6. Putative Protective Role of Sars-Cov-2-Specific T Cells in an HCT Patient Transplanted during Active COVID19 Infection

    Article • Transplantation and Cellular Therapy, March 2022, Elsevier

    Dr. Don J Diamond

  7. Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform

    Article • Nature Communications, November 2020, Springer Science + Business Media

    Dr. Don J Diamond

  8. Chimeric Antigen Receptors Targeting Human Cytomegalovirus

    Article • The Journal of Infectious Diseases, April 2020, Oxford University Press (OUP)

    Dr. Don J Diamond

  9. The Status of Vaccine Development Against the Human Cytomegalovirus

    Article • The Journal of Infectious Diseases, March 2020, Oxford University Press (OUP)

    Dr. Don J Diamond

  10. Cytomegalovirus-vectored vaccines for HIV and other pathogens

    Article • AIDS, March 2020, Wolters Kluwer Health

    Dr. Don J Diamond

  11. Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients

    Article • Annals of Internal Medicine, February 2020, American College of Physicians

    Dr. Don J Diamond

  12. Correction for Chiuppesi et al., “Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice”

    Article • Journal of Virology, December 2019, ASM Journals

    Dr. Don J Diamond

  13. MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission

    Article • Vaccines, November 2019, MDPI AG

    Dr. Don J Diamond

  14. Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice

    Article • PLoS ONE, September 2019, PLOS

    Dr. Don J Diamond

  15. Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth

    Article • Cancer Gene Therapy, March 2019, Springer Science + Business Media

    Dr. Don J Diamond

  16. Adaptive NK cell reconstitution is associated with better clinical outcomes

    Article • JCI Insight, January 2019, American Society for Clinical Investigation

    Dr. Don J Diamond

  17. A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection

    Article • Expert Review of Vaccines, October 2018, Taylor & Francis

    Dr. Don J Diamond, CORINNA LA ROSA

  18. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice

    Article • Journal of Virology, July 2018, ASM Journals

    Dr. Don J Diamond

  19. Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex

    Article • Journal of Virological Methods, January 2018, Elsevier

    Dr. Don J Diamond

  20. Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells

    Article • Vaccines, October 2017, MDPI AG

    Dr. Don J Diamond

  21. Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice

    Article • PLoS ONE, August 2017, PLOS

    Dr. Don J Diamond

  22. Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

    Article • JCI Insight, July 2017, American Society for Clinical Investigation

    Dr. Don J Diamond

  23. Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus

    Article • Journal of Virology, January 2017, ASM Journals

    Dr. Don J Diamond

  24. MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults

    Article • Blood, January 2017, American Society of Hematology

    Dr. Don J Diamond

  25. The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains

    Article • Journal of General Virology, June 2016, Society for General Microbiology

    Dr. Don J Diamond

  26. Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer

    Article • OncoImmunology, March 2016, Taylor & Francis

    Dr. Don J Diamond

  27. Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial

    Article • The Lancet Haematology, February 2016, Elsevier

    Dr. Don J Diamond

  28. Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients

    Article • Transplantation, January 2016, Wolters Kluwer Health

    Dr. Don J Diamond

  29. Maternal CD4 + T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission

    Article • Proceedings of the National Academy of Sciences, October 2015, Proceedings of the National Academy of Sciences

    Dr. Don J Diamond

  30. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT

    Article • Leukemia, September 2015, Springer Science + Business Media

    Dr. Don J Diamond

  31. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection

    Article • Journal of Virology, September 2015, ASM Journals

    Dr. Don J Diamond

  32. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin–Like Receptor–Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Trans...

    Article • Biology of Blood and Marrow Transplantation, September 2015, Elsevier

    Dr. Don J Diamond

  33. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection agains...

    Article • Vaccine, July 2015, Elsevier

    Dr. Don J Diamond

  34. Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors

    Article • Cancer Immunology Research, July 2015, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  35. CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells

    Article • Clinical Cancer Research, April 2015, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  36. Reduced Frequencies of Polyfunctional CMV-Specific T Cell Responses in Infants with Congenital CMV Infection

    Article • Journal of Clinical Immunology, February 2015, Springer Science + Business Media

    Dr. Don J Diamond

  37. Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex

    Article • PLoS Pathogens, November 2014, PLOS

    Dr. Don J Diamond

  38. Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation

    Article • Bone Marrow Transplantation, September 2014, Springer Science + Business Media

    Dr. Don J Diamond

  39. Effective Cancer Vaccine Platform Based on Attenuated Salmonella and a Type III Secretion System

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  40. Overcoming immunosuppression to enhance a p53MVA vaccine

    Article • OncoImmunology, September 2014, Taylor & Francis

    Dr. Don J Diamond

  41. p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses

    Article • Clinical Cancer Research, July 2014, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  42. Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine

    Article • Vaccine, June 2014, Elsevier

    Dr. Don J Diamond

  43. Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients

    Article • Transplant Immunology, May 2014, Elsevier

    Dr. Don J Diamond

  44. TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy

    Article • Cancer Research, October 2013, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  45. DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus

    Article • Human Vaccines & Immunotherapeutics, October 2013, Taylor & Francis

    Dr. Don J Diamond

  46. La Rosa C et al (J Infect Dis 2012; 205:1294-304)

    Article • The Journal of Infectious Diseases, August 2013, Oxford University Press (OUP)

    Dr. Don J Diamond

  47. Tumor Growth Control with IDO-Silencing Salmonella--Reply

    Article • Cancer Research, July 2013, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  48. Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms’ tumor antigen in patients with non-Hodgkin lymphoma

    Article • Leukemia & Lymphoma, April 2013, Taylor & Francis

    Dr. Don J Diamond

  49. A road less traveled paved by IDO silencing

    Article • OncoImmunology, March 2013, Taylor & Francis

    Dr. Don J Diamond

  50. Enhanced Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV Specific Central Memory T Cells by CMV Vaccine.

    Article • Blood, November 2012, American Society of Hematology

    Dr. Don J Diamond

  51. A Vaccine Based on the Rhesus Cytomegalovirus UL128 Complex Induces Broadly Neutralizing Antibodies in Rhesus Macaques

    Article • Journal of Virology, November 2012, ASM Journals

    Dr. Don J Diamond

  52. Systemic Delivery of Salmonella typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth

    Article • Cancer Research, October 2012, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  53. Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice

    Article • Clinical Cancer Research, August 2012, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  54. Patterns of Acute Rhesus Cytomegalovirus (RhCMV) Infection Predict Long-Term RhCMV Infection

    Article • Journal of Virology, April 2012, ASM Journals

    Dr. Don J Diamond

  55. Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant

    Article • The Journal of Infectious Diseases, March 2012, Oxford University Press (OUP)

    Dr. Don J Diamond

  56. Survivin the battle against immunosuppression

    Article • OncoImmunology, March 2012, Taylor & Francis

    Dr. Don J Diamond

  57. The immune response to human CMV

    Article • Future Virology, March 2012, Future Medicine

    Dr. Don J Diamond

  58. Recombinant Modified Vaccinia Virus Ankara (MVA) Expressing Wild-Type Human p53 Induces Specific Antitumor CTL Expansion

    Article • Cancer Investigation, August 2011, Taylor & Francis

    Dr. Don J Diamond

  59. Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice

    Article • Blood, June 2011, American Society of Hematology

    Dr. Don J Diamond

  60. Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients

    Article • Transplant International, June 2011, Frontiers

    Dr. Don J Diamond

  61. Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting Salmonella-Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors

    Article • Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  62. CD154 Expression Is Associated with Neutralizing Antibody Titer Levels Postinfluenza Vaccination in Stem Cell Transplant Patients and Healthy Adults

    Article • Biology of Blood and Marrow Transplantation, April 2011, Elsevier

    Dr. Don J Diamond

  63. Open Reading Frames Carried on UL/b' Are Implicated in Shedding and Horizontal Transmission of Rhesus Cytomegalovirus in Rhesus Monkeys

    Article • Journal of Virology, March 2011, ASM Journals

    Dr. Don J Diamond

  64. Vaccine-Induced Control of Viral Shedding following Rhesus Cytomegalovirus Challenge in Rhesus Macaques

    Article • Journal of Virology, December 2010, ASM Journals

    Dr. Don J Diamond

  65. Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity

    Article • Clinical Cancer Research, November 2010, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  66. Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model

    Article • Cancer Immunology Immunotherapy, October 2010, Springer Science + Business Media

    Dr. Don J Diamond

  67. Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses

    Article • Virology, August 2010, Elsevier

    Dr. Don J Diamond

  68. Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease

    Article • Transplant Infectious Disease, August 2010, Wiley

    Dr. Don J Diamond

  69. Heterologous Prime/Boost Immunization With p53-based Vaccines Combined With Toll-like Receptor Stimulation Enhances Tumor Regression

    Article • Journal of Immunotherapy, July 2010, Wolters Kluwer Health

    Dr. Don J Diamond

  70. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006–2007 and 2007–2008 seasons

    Article • Preventive Medicine, May 2010, Elsevier

    Dr. Don J Diamond

  71. Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines

    Article • Vaccine, February 2010, Elsevier

    Dr. Don J Diamond, Dr Ravindra K Rawal

  72. Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, July 2009, Elsevier

    Dr. Don J Diamond

  73. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

    Article • Blood, April 2009, American Society of Hematology

    Dr. Don J Diamond

  74. Mamu-A⁎01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development

    Article • Virology, April 2009, Elsevier

    Dr. Don J Diamond, Dr Ravindra K Rawal

  75. The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, March 2009, Elsevier

    Dr. Don J Diamond

  76. A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models

    Article • Immunology Letters, September 2008, Elsevier

    Dr. Don J Diamond

  77. A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector

    Article • Virology, August 2008, Elsevier

    Dr. Don J Diamond

  78. 402: PD-1 Expression is Linked to CMV Disease and Prolonged CMV Infection after HCT

    Article • Biology of Blood and Marrow Transplantation, February 2008, Elsevier

    Dr. Don J Diamond

  79. Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques

    Article • Medical Microbiology and Immunology, January 2008, Springer Science + Business Media

    Dr. Don J Diamond

  80. Programmed Death–1 Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease

    Article • The Journal of Infectious Diseases, January 2008, Oxford University Press (OUP)

    Dr. Don J Diamond

  81. Pre-Clinical Development of a Subunit Vaccine Expressing an IE1-IE2 Fusion Protein of HCMV.

    Article • Blood, November 2007, American Society of Hematology

    Dr. Don J Diamond

  82. Multicytokine and Polyfunctional CMV-Specific T Cells Are Associated with Stem Cell Transplant Donor CMV Serostatus.

    Article • Blood, November 2007, American Society of Hematology

    Dr. Don J Diamond

  83. Functional Characterization of BK Virus-Specific CD4+T Cells with Cytotoxic Potential in Seropositive Adults

    Article • Viral Immunology, September 2007, Mary Ann Liebert Inc

    Dr. Don J Diamond

  84. Oblimersen and α-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium

    Article • Journal of Cancer Research and Clinical Oncology, May 2007, Springer Science + Business Media

    Dr. Don J Diamond

  85. Longitudinal Assessment of Cytomegalovirus (CMV)–Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV Disease

    Article • The Journal of Infectious Diseases, March 2007, Oxford University Press (OUP)

    Dr. Don J Diamond

  86. An MVA vaccine overcomes tolerance to human p53 in mice and humans

    Article • Cancer Immunology Immunotherapy, January 2007, Springer Science + Business Media

    Dr. Don J Diamond

  87. Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1

    Article • Vaccine, January 2007, Elsevier

    Dr. Don J Diamond

  88. Functional Comparison of T Cells Recognizing Cytomegalovirus pp65 and Intermediate‐Early Antigen Polypeptides in Hematopoietic Stem‐Cell Transplant and Solid Organ Transplant Recipients

    Article • The Journal of Infectious Diseases, November 2006, Oxford University Press (OUP)

    Dr. Don J Diamond

  89. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals

    Article • Virology, June 2006, Elsevier

    Dr. Don J Diamond

  90. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara

    Article • Experimental Hematology, April 2006, Elsevier

    Dr. Don J Diamond

  91. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection

    Article • Journal of Clinical Virology, March 2006, Elsevier

    Dr. Don J Diamond

  92. Human cytomegalovirus vaccine: time to look for alternative options

    Article • Trends in Molecular Medicine, January 2006, Elsevier

    Dr. Don J Diamond, Professor Rajiv Khanna

  93. Peptide Libraries to CMV Antigens Predict Levels of Cytotoxic Function of CMV-Specific CTL Populations in PBMC from HSCT Recipients.

    Article • Blood, November 2005, American Society of Hematology

    Dr. Don J Diamond

  94. Cytomegalovirus Immune Reconstitution Occurs in Recipients of Allogeneic Hematopoietic Cell Transplants Irrespective of Detectable Cytomegalovirus Infection

    Article • Biology of Blood and Marrow Transplantation, November 2005, Elsevier

    Dr. Don J Diamond

  95. Cross-Reactivity of T Lymphocytes Recognizing a Human Cytotoxic T-Lymphocyte Epitope within BK and JC Virus VP1 Polypeptides

    Article • Journal of Virology, September 2005, ASM Journals

    Dr. Don J Diamond

  96. Lack of association of cytomegalovirus with human brain tumors

    Article • Modern Pathology, June 2005, Elsevier

    Dr. Don J Diamond

  97. Novel conjugates of epitope fusion peptides with CpG-ODN display enhanced immunogenicity and HIV recognition

    Article • Vaccine, May 2005, Elsevier

    Dr. Don J Diamond

  98. Simultaneous Reconstitution of Multiple Cytomegalovirus‐Specific CD8 + Cell Populations with Divergent Functionality in Hematopoietic Stem‐Cell Transplant Recipients

    Article • The Journal of Infectious Diseases, March 2005, Oxford University Press (OUP)

    Dr. Don J Diamond

  99. Reduced Type 1 and Type 2 Cytokines in Antiviral Memory T Helper Function Among Women Coinfected with HIV and HCV

    Article • Journal of Clinical Immunology, March 2005, Springer Science + Business Media

    Dr. Don J Diamond

  100. Characterization of Host Immunity to cytomegalovirus pp150 (UL32)

    Article • Human Immunology, February 2005, Elsevier

    Dr. Don J Diamond

  101. DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice

    Article • Vaccine, December 2004, Elsevier

    Dr. Don J Diamond

  102. Two Distinct Pathways of Immuno-Modulation Improve Potency of p53 Immunization in Rejecting Established Tumors

    Article • Cancer Research, August 2004, American Association for Cancer Research (AACR)

    Dr. Don J Diamond

  103. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants

    Article • Biology of Blood and Marrow Transplantation, July 2004, Elsevier

    Dr. Don J Diamond

  104. Predominant type 1 CMV-Specific memory T-helper response in humans: evidence for gender differences in cytokine secretion

    Article • Human Immunology, May 2004, Elsevier

    Dr. Don J Diamond

  105. Recombinant Modified Vaccinia Virus Ankara Expressing a Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus

    Article • Journal of Virology, April 2004, ASM Journals

    Dr. Don J Diamond

  106. Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells

    Article • Blood, April 2004, American Society of Hematology

    Dr. Don J Diamond

  107. Relevance of Peptide Avidity to the T Cell Receptor for Cytomegalovirus‐Specific Ex Vivo CD8 T Cell Cytotoxicity

    Article • The Journal of Infectious Diseases, September 2003, Oxford University Press (OUP)

    Dr. Don J Diamond

  108. Relative dominance of HLA-B*07 restricted CD8+ T-Lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles

    Article • Human Immunology, April 2003, Elsevier

    Dr. Don J Diamond

  109. A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells

    Article • Cancer Immunology Immunotherapy, November 2002, Springer Science + Business Media

    Dr. Don J Diamond

  110. Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants

    Article • Transplantation, September 2002, Wolters Kluwer Health

    Dr. Don J Diamond

  111. Erratum

    Article • Scandinavian Journal of Immunology, August 2002, Wiley

    Dr. Don J Diamond

  112. Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice

    Article • Blood, July 2002, American Society of Hematology

    Dr. Don J Diamond

  113. Kinase-Deficient CMVpp65 Triggers a CMVpp65 Specific T-Cell Immune Response in HLA-A*0201.Kb Transgenic Mice after DNA Immunization

    Article • Scandinavian Journal of Immunology, June 2002, Wiley

    Dr. Don J Diamond

  114. Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses

    Article • Immunology, April 2002, Wiley

    Dr. Don J Diamond

  115. Human Immunodeficiency Virus–Infected Patients Receiving Highly Active Antiretroviral Therapy Maintain Activated CD8 + T Cell Subsets as a Strong Adaptive Immune Response to Cytomegalovirus

    Article • The Journal of Infectious Diseases, August 2001, Oxford University Press (OUP)

    Dr. Don J Diamond

  116. Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries

    Article • Blood, March 2001, American Society of Hematology

    Dr. Don J Diamond

  117. Infrequent Occurrence of Natural Mutations in the pp65495–503 Epitope Sequence Presented by the HLA A∗0201 Allele among Human Cytomegalovirus Isolates

    Article • Journal of Virology, March 2001, ASM Journals

    Dr. Don J Diamond

  118. Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting

    Article • Vaccine, February 2001, Elsevier

    Dr. Don J Diamond

  119. Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes

    Article • Immunogenetics, January 2001, Springer Science + Business Media

    Dr. Don J Diamond

  120. Induction of CTL response by a minimal epitope vaccine in HLA A∗0201/DR1 transgenic mice: dependence on HLA class II restricted TH response

    Article • Human Immunology, August 2000, Elsevier

    Dr. Don J Diamond

  121. Status of Cytomegalovirus Prevention and Treatment in 2000

    Article • Hematology, January 2000, American Society of Hematology

    Dr. Don J Diamond

  122. IMMUNOTHERAPY OF BLADDER CANCER TARGETING P53

    Article • The Journal of Urology, November 1999, Wolters Kluwer Health

    Dr. Don J Diamond

  123. IMMUNOTHERAPY OF BLADDER CANCER TARGETING P53

    Article • The Journal of Urology, November 1999, Wolters Kluwer Health

    Dr. Don J Diamond

  124. An orthotopic in vivo model of human pancreatic cancer

    Article • Surgery, September 1999, Elsevier

    Dr. Don J Diamond

  125. CTL epitope as an immunotherapeutic strategy against CMV infection

    Article • Journal of Clinical Virology, April 1999, Elsevier

    Dr. Don J Diamond

  126. An HLA-restricted, p53 specific immune response from HLA transgenic p53 knockout mice

    Article • Annals of Surgical Oncology, January 1998, Springer Science + Business Media

    Dr. Don J Diamond

  127. The Use of Transgenic Mice to Generate High Affinity p53 Specific Cytolytic T Cells

    Article • Journal of Surgical Research, May 1997, Elsevier

    Dr. Don J Diamond

  128. IMMUNOHISTOCHEMICAL ANALYSIS OF T CELL PHENOTYPES IN PATIENTS WITH GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION

    Article • Transplantation, May 1995, Wolters Kluwer Health

    Dr. Don J Diamond

  129. Immunochemical and molecular analysis of antigen binding to lipid anchored and soluble forms of an mhc independent human α/β T cell receptor

    Article • Molecular Immunology, August 1994, Elsevier

    Dr. Don J Diamond

  130. Characterization of nuclear protein binding to the interferon‐γ promoter in quiescent and activated human T cells

    Article • European Journal of Immunology, September 1992, Wiley

    Dr. Don J Diamond

  131. The human interferon‐γ gene contains an inducible promoter that can be transactivated by tax I and II

    Article • European Journal of Immunology, August 1991, Wiley

    Dr. Don J Diamond

  132. Unusual organization and diversity of T-cell receptor a-chain genes

    Article • Nature, August 1985, Springer Science + Business Media

    Dr. Don J Diamond

  133. Effects of Rat Growth Hormone (rGH)-Releasing Factor and Somatostatin on the Release and Synthesis of rGH in Dispersed Pituitary Cells*

    Article • Endocrinology, August 1985, Endocrine Society

    Dr. Don J Diamond

  134. Regulation of growth hormone messenger RNA synthesis by dexamethasone and triiodothyronine

    Article • Journal of Molecular Biology, January 1985, Elsevier

    Dr. Don J Diamond

  135. Disproportionate expression of the two nonallelic rat insulin genes in a pancreatic tumor is due to translational control

    Article • Cell, December 1982, Elsevier

    Dr. Don J Diamond

  136. Structure, Expression, and Evolution of Growth Hormone Genes

    Article • January 1982, Elsevier

    Dr. Don J Diamond

  137. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination

    Article • Biochemistry, October 1977, American Chemical Society (ACS)

    Dr. Don J Diamond